Cefepime (INN) (IPA: ) is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime hydrochloride was first marketed in 1994 and is currently marketed under various trade names including Maxipime (Elan Pharma), Maxcef, Cepimax, Cepimex, and Axepim.

Clinical use

---

Cefepime is usually reserved to treat severe nosocomial pneumonia, infections caused by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.

More on [ Cefepime ]

CFDA: FDA Latest Computer Systems Warning Letters

WL Issued to Oncology Tech, LLP
FDA Fri, 27 Jun 2008 00:00:00 -0400
FDA Warning Letter Issued to Oncology Tech, LLP on 27 Jun 2008 by Dallas District Office
WL Issued to Mostel, Edward, M.D.
FDA Fri, 16 May 2008 00:00:00 -0400
FDA Warning Letter Issued to Mostel, Edward, M.D. on 16 May 2008 by Center for Drug Evaluation and Research
WL Issued to Merck & Company, Inc.
FDA Mon, 28 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Merck & Company, Inc. on 28 Apr 2008 by Office of Enforcement
WL Issued to Blood Center of New Jersey
FDA Tue, 15 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Blood Center of New Jersey on 15 Apr 2008 by New Jersey District Office
WL Issued to Asfora, Wilson T. M.D.
FDA Mon, 07 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Asfora, Wilson T. M.D. on 07 Apr 2008 by Center for Devices and Radiological Health
WL Issued to Philips Medical Systems, Inc
FDA Tue, 01 Apr 2008 00:00:00 -0400
FDA Warning Letter Issued to Philips Medical Systems, Inc on 01 Apr 2008 by Cincinnati District Office

CFDA: FDA Latest Drug GCP Warning Letters

WL Issued to Gardiziola, Gregory, D.O.
FDA Wed, 03 Sep 2008 00:00:00 -0400
FDA Warning Letter Issued to Gardiziola, Gregory, D.O. on 03 Sep 2008 by Center for Drug Evaluation and Research
WL Issued to Hamilton Medical Center
FDA Tue, 02 Sep 2008 00:00:00 -0400
FDA Warning Letter Issued to Hamilton Medical Center on 02 Sep 2008 by Center for Devices and Radiological Health
WL Issued to Ziran, Bruce H., MD
FDA Wed, 27 Aug 2008 00:00:00 -0400
FDA Warning Letter Issued to Ziran, Bruce H., MD on 27 Aug 2008 by Center for Devices and Radiological Health
WL Issued to Hospital Municipal de San Juan
FDA Fri, 15 Aug 2008 00:00:00 -0400
FDA Warning Letter Issued to Hospital Municipal de San Juan on 15 Aug 2008 by Center for Drug Evaluation and Research
WL Issued to Valley Baptist Medical Center IRB
FDA Mon, 11 Aug 2008 00:00:00 -0400
FDA Warning Letter Issued to Valley Baptist Medical Center IRB on 11 Aug 2008 by Center for Devices and Radiological Health
WL Issued to Husain, Mustafa M, M.D.
FDA Wed, 23 Jul 2008 00:00:00 -0400
FDA Warning Letter Issued to Husain, Mustafa M, M.D. on 23 Jul 2008 by Center for Devices and Radiological Health

Subscribe to Drugs_and_Medications RSS feed